Maarten Anderegg

679 total citations
16 papers, 458 citations indexed

About

Maarten Anderegg is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Maarten Anderegg has authored 16 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Maarten Anderegg's work include Gastric Cancer Management and Outcomes (12 papers), Esophageal Cancer Research and Treatment (12 papers) and Esophageal and GI Pathology (7 papers). Maarten Anderegg is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Esophageal Cancer Research and Treatment (12 papers) and Esophageal and GI Pathology (7 papers). Maarten Anderegg collaborates with scholars based in Netherlands, Israel and United Kingdom. Maarten Anderegg's co-authors include Mark I. van Berge Henegouwen, Suzanne S. Gisbertz, Hanneke W.M. van Laarhoven, Martijn G.H. van Oijen, Hiroaki Wakimoto, Khalid Shah, Tugba Bagcı-Önder, Nadia Haj Mohammad, Maarten C.C.M. Hulshof and Emil ter Veer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Maarten Anderegg

16 papers receiving 454 citations

Peers

Countries citing papers authored by Maarten Anderegg

Since Specialization

Citations

This map shows the geographic impact of Maarten Anderegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Anderegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Anderegg more than expected).

Fields of papers citing papers by Maarten Anderegg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Anderegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Anderegg. The network helps show where Maarten Anderegg may publish in the future.

Co-authorship network of co-authors of Maarten Anderegg

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Anderegg. A scholar is included among the top collaborators of Maarten Anderegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Anderegg. Maarten Anderegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	18F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction: Accuracy and Long-Term Implications 2023 ·Journal of Gastrointestinal Cancer ·(unknown), Suzanne S. Gisbertz, Maarten Anderegg, Sjoerd M. Lagarde, Remy Klaassen, Sybren L. Meijer, Susan van Dieren, (unknown), JJGHM Bergman, Roel J. Bennink, Hanneke W.M. van Laarhoven, Mark I. van Berge Henegouwen	1
2	Learning inguinal hernia repair? A survey of current practice and of preferred methods of surgical residents 2020 ·Hernia ·(unknown), Mary Dankbaar, David L. Sanders, Maarten Anderegg, Theo Wiggers, M. P. Simons	7
3	International Survey on the Management of Anastomotic Leakage After Esophageal Resection 2018 ·The Annals of Thoracic Surgery ·Eliza Hagens, Maarten Anderegg, Mark I. van Berge Henegouwen, Suzanne S. Gisbertz	28
4	Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis 2017 ·Scientific Reports ·Emil ter Veer, Lok Lam Ngai, Gert van Valkenhoef, Nadia Haj Mohammad, Maarten Anderegg, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven	20
5	Effect of goal-directed therapy on outcome after esophageal surgery: A quality improvement study 2017 ·PLoS ONE ·Denise P. Veelo, Mark I. van Berge Henegouwen, (unknown), Bart F. Geerts, Maarten Anderegg, Susan van Dieren, Benedikt Preckel, Jan M. Binnekade, Suzanne S. Gisbertz, Markus W. Hollmann	34
6	Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma 2017 ·Annals of Surgical Oncology ·Maarten Anderegg, (unknown), Jelle P. Ruurda, Suzanne S. Gisbertz, Maarten C.C.M. Hulshof, Marco van Vulpen, (unknown), Hanneke W.M. van Laarhoven, Marinus J. Wiezer, Maartje Los, Mark I. van Berge Henegouwen, Richard van Hillegersberg	31
7	Treatment strategies in recurrent esophageal or junctional cancer 2017 ·Diseases of the Esophagus ·(unknown), Sjoerd M. Lagarde, Martijn G.H. van Oijen, Maarten Anderegg, Suzanne S. Gisbertz, Sybren L. Meijer, Maarten C.C.M. Hulshof, Jacques Bergman, Mark I. van Berge Henegouwen, Hanneke W.M. van Laarhoven	27
8	Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction 2016 ·Annals of Surgery ·Maarten Anderegg, Sjoerd M. Lagarde, (unknown), Suzanne S. Gisbertz, Arul Immanuel, Sybren L. Meijer, Maarten C.C.M. Hulshof, Jacques Bergman, Hanneke W.M. van Laarhoven, S M Griffin, Mark I. van Berge Henegouwen	30
9	The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis 2016 ·JNCI Journal of the National Cancer Institute ·Emil ter Veer, Nadia Haj Mohammad, Gert van Valkenhoef, Lok Lam Ngai, (unknown), Maarten Anderegg, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven	86
10	Patients with oesophageal cancer report elevated distress and problems yet do not have an explicit wish for referral prior to receiving their medical treatment plan 2016 ·Psycho-Oncology ·M. Jacobs, Maarten Anderegg, Annuska Schoorlemmer, Daan Nieboer, Ewout W. Steyerberg, Ellen M.A. Smets, Mirjam A. G. Sprangers, Mark I. van Berge Henegouwen, J.C.J.M. de Haes, (unknown)	9
11	18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making 2015 ·PLoS ONE ·Maarten Anderegg, E. Joline de Groof, Suzanne S. Gisbertz, Roel J. Bennink, Sjoerd M. Lagarde, Jean H. G. Klinkenbijl, Marcel G. W. Dijkgraaf, Jacques Bergman, Maarten C.C.M. Hulshof, Hanneke W.M. van Laarhoven, Mark I. van Berge Henegouwen	22
12	Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent 2015 ·Supportive Care in Cancer ·Nadia Haj Mohammad, (unknown), Martijn G.H. van Oijen, Maarten C.C.M. Hulshof, Jacques Bergman, Maarten Anderegg, Mark I. van Berge Henegouwen, Inge Henselmans, M. A. G. Sprangers, Hanneke W.M. van Laarhoven	32
13	Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes 2015 ·Annals of Surgical Oncology ·(unknown), Sjoerd M. Lagarde, Martijn G.H. van Oijen, Suzanne S. Gisbertz, Johanna W. Wilmink, Maarten C.C.M. Hulshof, Sybren L. Meijer, Maarten Anderegg, Mark I. van Berge Henegouwen, Hanneke W.M. van Laarhoven	18
14	Survival after pathologic complete response in patients with cancer of the esophagus or gastroesophageal junction. 2014 ·Journal of Clinical Oncology ·Sjoerd M. Lagarde, Maarten Anderegg, Wernard A. A. Borstlap, Suzanne S. Gisbertz, Sybren L. Meijer, Maarten C.C.M. Hulshof, Jacques Bergman, Hanneke W.M. van Laarhoven, Mark I. van Berge Henegouwen	1
15	Minimally invasive surgery for oesophageal cancer 2013 ·Best Practice & Research Clinical Gastroenterology ·Maarten Anderegg, Suzanne S. Gisbertz, Mark I. van Berge Henegouwen	24
16	A Dual PI3K/mTOR Inhibitor, PI-103, Cooperates with Stem Cell–Delivered TRAIL in Experimental Glioma Models 2010 ·Cancer Research ·Tugba Bagcı-Önder, Hiroaki Wakimoto, Maarten Anderegg, (unknown), Khalid Shah	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact